Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report
Monitoring Agency Report for Quarter ended Dec 31, 2023.10-02-2024
10-02-2024
Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Dear Sir(s), Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find the link Audio Recording of Earnings Conference Call held on Friday, February 9, 2024, hosted by Motilal Oswal, for the third quarter and nine months ended December 31, 2023 results of the Company.09-02-2024
Global Health Results Earnings Call for Q3FY24
Conference Call with Global Health Management and Analysts on Q3FY24 Performance and Outlook. Listen to the full earnings transcript.09-02-2024
Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication for Dec 31, 2023 Financial Results of the Company.09-02-2024
Q3FY24 Quarterly Result Announced for Global Health Ltd.
Healthcare Facilities company Global Health announced Q3FY24 results: Financial Performance: Total Income: The consolidated total income for Global Health increased by 21% YoY to Rs 8,545 million in Q3FY24. EBITDA: The company's EBITDA saw a substantial rise of 36% YoY, reaching Rs 2,340 million, with EBITDA margins expanding significantly by 305 basis points to 27.4%. Net Profit: Net profit experienced remarkable growth, up by 53% YoY to Rs 1,235 million, while the PAT margins improved from 11.4% to 14.5%. Operational Highlights: Bed Occupancy: The average occupied bed days increased by 15% YoY, which corresponds to an average occupancy rate of 64% for the quarter. Patient Volume: The company reported a 13% YoY increase in in-patient count and a 20% YoY increase in out-patient count. Average Revenue Per Occupied Bed (ARPOB): ARPOB saw a growth of 4% YoY, reaching Rs 60,571, primarily driven by higher realizations at the Gurugram unit. Business Growth: Developing Hospitals Performance: Developing hospitals witnessed revenue growth of 33%, contributing Rs 2,742 million, which amounted to 32% of the total revenue share. Their EBITDA contribution increased from 37% to 41%, summing up to Rs 968 million. Matured Hospitals Performance: The matured hospitals also demonstrated strong performance, with a revenue increase of 17% and EBITDA growth of 37%, totaling Rs 5,875 million and Rs 1,484 million respectively. International Patients Revenue: Revenue from international patients rose by 6% YoY to Rs 473 million, owing to increased volume and realization. OPD Pharmacy Business: There was a 28% YoY increase in revenue from the OPD pharmacy business, up from Rs 224 million in Q3 FY23 to Rs 287 million in Q3 FY24. Strategic Developments: Doctor Onboarding: Medanta onboarded a total of 253 doctors across their facilities during the first nine months of FY24, with 159 in matured hospitals and 94 in developing hospitals. Upcoming Hospital in Noida: Progress on the Medanta Noida hospital is well on track with the superstructure 82% complete and operations expected to start by the end of FY2025. New Joint Venture: Medanta and DLF formed a special-purpose vehicle company, GHL Hospital Limited, to construct and operate a super-specialty hospital in South Delhi. Pankaj Sahni, Group CEO, and Director, said: "I am pleased to report that Medanta has delivered strong year-on-year performance during the quarter ended December 31, 2023. In Q3FY24, both our matured and developing units delivered robust revenue growth of 17% and 33% YoY respectively. This growth was primarily driven by increased in-patient volume and improved realization. Our commitment remains unwavering in building a sustainable long-term business model and providing the highest quality care across our key markets." Result PDF09-02-2024
Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release for the December 31, 2023 Results of the Company.08-02-2024
Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation for December 31, 2023 Results of the Company.08-02-2024
Global Health Ltd - 543654 - Statement Of Deviation/Variation In Utilization Of Funds Raised Through Initial Public Offer For The Quarter Ended December 31, 2023.
Statement of Deviation/variation in utilization of funds raised by IPO , for Quarter ended Dec 31, 2023.08-02-2024
Medanta Q3 results: Net Profit up 53% to Rs 124crore
Global Health, which operates Medanta, had reported a 46 percent year-on-year (YoY) rise in net profit at Rs 125 crore for the July-September period08-02-2024
Global Health Ltd - 543654 - Appointment Of KMP/CFO
Appointment of KMP/CFO w.e.f. February 8, 2024.08-02-2024